← FDA DRUG APPROVALS

FDA NDA · NDA212860

TRIFERIC AVNU

Sponsor: ROCKWELL MEDICAL INC

APPLICATION
NDA212860
TYPE
NDA
ORIGINAL APPROVAL
2020-03-27
LATEST ACTION
2023-07-28
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

TRIFERIC AVNU · ReferenceDiscontinued
FERRIC PYROPHOSPHATE CITRATE 6.75MG IRON/4.5ML (1.5MG IRON/ML) · SOLUTION · INTRAVENOUS

Approval history

2023-07-28Labeling · Supplement 1 · standardLetterAP
2020-03-27Type 3 - New Dosage Form · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →